119 related articles for article (PubMed ID: 36963347)
1. Growth associated protein 43 deficiency promotes podocyte injury by activating the calmodulin/calcineurin pathway under hyperglycemia.
Yang Y; Shi W; Li C; Li L; Li J; Chen Y; Shi Q; Xie Z; Wang M; Zhang H; Zhao X; Chen Y; Li R; Liu S; Ye Z; Zhang L; Liang X
Biochem Biophys Res Commun; 2023 May; 656():104-114. PubMed ID: 36963347
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
[TBL] [Abstract][Full Text] [Related]
3. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
[TBL] [Abstract][Full Text] [Related]
4. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
5. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
[TBL] [Abstract][Full Text] [Related]
7. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
Shen Y; Chen S; Zhao Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950
[TBL] [Abstract][Full Text] [Related]
8. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
9. Complement factor B in high glucose-induced podocyte injury and diabetic kidney disease.
Lu Q; Hou Q; Cao K; Sun X; Liang Y; Gu M; Xue X; Zhao AZ; Dai C
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622800
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway.
Wang X; Jiang L; Liu XQ; Huang YB; Wang AL; Zeng HX; Gao L; Zhu QJ; Xia LL; Wu YG
Phytomedicine; 2022 Nov; 106():154400. PubMed ID: 36049428
[TBL] [Abstract][Full Text] [Related]
12. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
13. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
14. High glucose induces Nox4 expression and podocyte apoptosis through the Smad3/ezrin/PKA pathway.
Guo W; Gao H; Pan W; Yu P; Che G
Biol Open; 2021 May; 10(5):. PubMed ID: 33046439
[TBL] [Abstract][Full Text] [Related]
15. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
16. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
17. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
[TBL] [Abstract][Full Text] [Related]
18. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R
Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942
[TBL] [Abstract][Full Text] [Related]
19. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]